4.8 Article

Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread

Journal

JOURNAL OF HEPATOLOGY
Volume 77, Issue 4, Pages 957-966

Publisher

ELSEVIER
DOI: 10.1016/j.jhep.2022.05.023

Keywords

hepatitis D virus; hepatitis B virus; cell division-mediated spread; virus-induced interferon response; interferon therapy; viral persistence

Funding

  1. German Center for Infectious Research (DZIF) , TTU Hepatitis Projects [5.709, 5.822]
  2. Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [272983813 - TRR 179]

Ask authors/readers for more resources

This study reveals that interferons can efficiently suppress the spread of hepatitis D virus (HDV) through cell division. The HDV-induced interferon response and exogenous interferon treatment both inhibit cell division-mediated HDV spread and accelerate HDV RNA decay.
Background & aims: Besides HBV-dependent de novo infection, cell division-mediated spread contributes to HDV persistence and dampens the effect of antivirals that abrogate de novo infection. Nonetheless, the combination of these antivirals with interferons (IFNs) showed strong synergism in recent clinical trials, implying a complementary mode-of-action of IFNs. Therefore, we investigated the effect of IFN response on cell division-mediated HDV spread. Methods: Cells infected with HDV were passaged to undergo cell division. The effect of the IFN response was evaluated by block-ing HDV-induced IFN activation, by applying different IFN treatment regimens, and by adjusting HDV infection doses. Results: Cell division-mediated HDV spread was highly efficient following infection of HuH7NTCP cells (defective in IFN production), but profoundly restricted in infected IFN-competent HepaRGNTCP cells. Treatment with IFN-a/-k1 inhibited HDV spread in dividing HuH7NTCP cells, but exhibited a marginal effect on HDV replication in resting cells. Blocking the HDV-induced IFN response with the JAK1/2 inhibitor ruxolitinib or knocking down MDA5 augmented HDV spread in dividing HepaRGNTCP cells. The virus-induced IFN response also destabilized HDV RNA in dividing cells. Moreover, the effect of exogenous IFNs on cell division-mediated HDV spread was more pronounced at low multiplicities of infection with weak virus-induced IFN responses. Conclusions: Both HDV-induced IFN response and exogenous IFN treatment suppress cell division-mediated HDV spread, presumably through acceleration of HDV RNA decay. Our find-ings demonstrate a novel mode-of-action of IFN, explain the more pronounced effect of IFN therapy in patients with lower HDV serum RNA levels, and provide insights for the development of combination therapies. Lay summary: Chronic hepatitis D is a major health problem. The causative pathogen hepatitis D virus (HDV) can propagate through viral particle-mediated infection and the division of infected cells. Although viral particle-dependent infection can be blocked by recently developed drugs, therapies addressing the cell division route have not been reported. Taking advantage of relevant cell culture models, we demonstrate that the widely used immune modulator interferon can efficiently suppress HDV spread through cell division. This work unveils a new function of interferon and sheds light on potentially curative combina-tion therapies. (c) 2022 The Author(s). Published by Elsevier B.V. on behalf of Euro-pean Association for the Study of the Liver. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Predicting the mutational drivers of future SARS-CoV-2 variants of concern

M. Cyrus Maher, Istvan Bartha, Steven Weaver, Julia di Iulio, Elena Ferri, Leah Soriaga, Florian A. Lempp, Brian L. Hie, Bryan Bryson, Bonnie Berger, David L. Robertson, Gyorgy Snell, Davide Corti, Herbert W. Virgin, Sergei L. Kosakovsky Pond, Amalio Telenti

Summary: This study predicts future variants of SARS-CoV-2 by analyzing various factors affecting its evolution, including ACE2-mediated transmissibility and host immunity. The researchers successfully identified mutations that will emerge in different phases of the pandemic and assessed their impact on therapeutic antibodies. This modeling approach has important implications for predicting emerging variants of SARS-CoV-2 and can be applied to other rapidly evolving pathogens.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Microbiology

A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo

Christian Heuss, Paul Rothhaar, Rani Burm, Ji-Young Lee, Philipp Ralfs, Uta Haselmann, Luisa J. Stroh, Ombretta Colasanti, Cong Si Tran, Noemi Schafer, Paul Schnitzler, Uta Merle, Ralf Bartenschlager, Arvind H. Patel, Frederik Graw, Thomas Krey, Vibor Laketa, Philip Meuleman, Volker Lohmann

Summary: This study reports an efficient infectious cell culture model for hepatitis C virus (HCV), which can be used for studying infection mechanisms and developing vaccines. The model, generated from a consensus gt1b genome, underwent long-term passaging to adapt and produce high levels of transmissible infectivity. The study's findings are important for understanding the transmission mechanisms of HCV and for research and prevention of HCV.

PLOS PATHOGENS (2022)

Review Cell Biology

A snapshot of protein trafficking in SARS-CoV-2 infection

Vibhu Prasad, Ralf Bartenschlager

Summary: This review highlights the cellular trafficking factors, processes, and organelles relevant to the SARS-CoV-2 infection cycle and how viral proteins exploit and disrupt cellular transport.

BIOLOGY OF THE CELL (2023)

Review Biochemistry & Molecular Biology

Medical Advances in Hepatitis D Therapy: Molecular Targets

Amelie Vogt, Sabrina Wohlfart, Stephan Urban, Walter Mier

Summary: The article discusses the issue of coinfection with hepatitis B and D viruses and the latest developments in treatment, emphasizing the importance of understanding the viral lifecycle in the development of new therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Gastroenterology & Hepatology

Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replication

Nadine Gillich, Zhenfeng Zhang, Marco Binder, Stephan Urban, Ralf Bartenschlager

Summary: This study reveals that LGP2 is essential for the recognition of HDV through MDA5-mediated antiviral interferon (IFN) response. LGP2 induces IFN through RNA binding and ATPase activity, and stabilizes MDA5-RNA interaction for downstream signaling. The variant Q425R of LGP2 exhibits stronger inhibition on HDV infection and IFN response, and may contribute to a milder course of hepatitis D.

JOURNAL OF HEPATOLOGY (2023)

Article Multidisciplinary Sciences

Structural conservation of HBV-like capsid proteins over hundreds of millions of years despite the shift from non-enveloped to enveloped life-style

Sara Pfister, Julius Rabl, Thomas Wiegand, Simone Mattei, Alexander A. Malaer, Lauriane Lecoq, Stefan Seitz, Ralf Bartenschlager, Anja Boeckmann, Michael Nassal, Daniel Boehringer, Beat H. Meier

Summary: The discovery of nackednaviruses provides new insight into the evolutionary history of hepatitis B virus (HBV). Both HBV and nackednaviruses share a common ancestor, but HBV acquired an envelope during evolution while nackednaviruses remained non-enveloped. The capsid structure of African cichlid nackednavirus (ACNDV) is very similar to HBV, with only minor structural differences.

NATURE COMMUNICATIONS (2023)

Article Gastroenterology & Hepatology

Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice

Florian A. Lempp, Tassilo Volz, Elisabetta Cameroni, Fabio Benigni, Jiayi Zhou, Laura E. Rosen, Julia Noack, Fabrizia Zatta, Hannah Kaiser, Siro Bianchi, Gloria Lombardo, Stefano Jaconi, Lucia Vincenzetti, Hasan Imam, Leah B. Soriaga, Nadia Passini, David M. Belnap, Andreas Schulze, Marc Luetgehetmann, Amalio Telenti, Andrea L. Cathcart, Gyorgy Snell, Lisa A. Purcell, Christy M. Hebner, Stephan Urban, Maura Dandri, Davide Corti, Michael A. Schmid

Summary: This study describes a monoclonal antibody that targets the surface antigen of hepatitis B virus (HBV) and shows potential for treating chronic hepatitis B and chronic hepatitis D. The antibody effectively neutralizes HBV and HDV infections in vitro and reduces viral levels in human liver-chimeric mice.

JOURNAL OF HEPATOLOGY (2023)

Article Virology

BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort Study

Claudius Speer, Maximilian Toellner, Louise Benning, Marie Bartenschlager, Heeyoung Kim, Christian Nusshag, Florian Kaelble, Marvin Reineke, Paula Reichel, Paul Schnitzler, Martin Zeier, Christian Morath, Wilhelm Schmitt, Raoul Bergner, Ralf Bartenschlager, Hanns-Martin Lorenz, Matthias Schaier

Summary: Emerging omicron subtypes with immune escape result in inadequate vaccine response in immunocompromised individuals like AAV patients. There is limited data on SARS-CoV-2 vaccination in AAV patients, and safety concerns exist regarding the use of mRNA vaccines in autoimmune diseases. This study provides insights into the neutralizing antibody response and reactogenicity of vaccines in AAV patients.

VIRUSES-BASEL (2023)

Article Microbiology

Endosomal egress and intercellular transmission of hepatic ApoE-containing lipoproteins and its exploitation by the hepatitis C virus

Minh-Tu Pham, Ji-Young Lee, Christian Ritter, Roman Thielemann, Janis E. Meyer, Uta A. Haselmann, Charlotta E. Funaya, Vibor A. Laketa, Karl E. Rohr, Ralf A. Bartenschlager

Summary: Using imaging analyses, the study reveals that ApoE-LPs are stored in CD63-positive endosomes and released into circulation. The co-egress of ApoE-LPs and EVs along the late endosomal route and their transmission between cells are also observed. The hepatitis C virus hijacks this pathway to produce ApoE-associated EVs containing viral RNA. This research provides important insights into the role of ApoE in various diseases and the mechanism of cell-to-cell communication.

PLOS PATHOGENS (2023)

Article Computer Science, Information Systems

Multi-Channel Colocalization Analysis and Visualization of Viral Proteins in Fluorescence Microscopy Images

Christian Ritter, Roman Thielemann, Ji-Young Lee, Minh Tu Pham, Ralf Bartenschlager, Karl Rohr

Summary: We introduce a software suite, consisting of ColocQuant and ColocJ, for colocalization analysis of spot-like objects in multi-channel fluorescence microscopy images. It provides efficient quantification and intuitive visualization of colocalization in two or three channels, as well as global statistics of particle properties. The software has been successfully applied to analyze live cell fluorescence microscopy image sequences of viral proteins in hepatitis C virus infected cells.

IEEE ACCESS (2023)

Article Gastroenterology & Hepatology

Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen

Bingqian Qu, Firat Nebioglu, Mila M. Leuthold, Yi Ni, Pascal Mutz, Juergen Beneke, Holger Erfle, Florian W. R. Vondran, Ralf Bartenschlager, Stephan Urban

Summary: Neddylation pathway plays a crucial role in HBV infection and integration of viral DNA, and blocking this pathway may offer an attractive approach for the functional cure of chronic hepatitis B.

JHEP REPORTS (2022)

No Data Available